Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BACR & ECMC: Therapeutic interventions for cancer prevention /
The future of cancer prevention

18th - 19th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.08.16
Views: 1867

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom

Prof Cuzick speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about the future of cancer prevention.

With the example of tamoxifen in breast cancer, he describes the need for research and advocacy in chemoprevention to advance current understandings of aspirin, metformin and as-yet-unidentified factors that could reduce the likelihood of cancer in populations.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation